Display Settings:

Format

Send to:

Choose Destination
    J Cardiovasc Electrophysiol. 2006 Apr;17(4):396-401.

    Increased intra-QRS fragmentation in magnetocardiography as a predictor of arrhythmic events and mortality in patients with cardiac dysfunction after myocardial infarction.

    Source

    Division of Cardiology, Helsinki University Central Hospital, PL 340, 00029 Hus, Finland. korhonen.petri@kolumbus.fi

    Abstract

    INTRODUCTION:

    Increased intra-QRS fragmentation score (FRA) in magnetocardiography (MCG) has shown association with sustained ventricular arrhythmias in post-MI patients suggesting its relation to arrhythmia substrate. The aim of this study was to investigate whether increased FRA in MCG predicts arrhythmic events and mortality after acute myocardial infarction (MI) with cardiac dysfunction.

    METHODS AND RESULTS:

    A series of 158 patients with acute MI and left ventricular ejection fraction (LVEF) <50% were studied. Their age was 60 +/- 10 years and LVEF 40 +/- 6%. MCG was registered and FRA was computed. For comparison, QRS duration in 12-lead ECG was measured. In a mean follow-up of 50 +/- 15 months, 32 (20%) patients died and 18 (11%) had an arrhythmic event. Both arrhythmic event rate and all-cause mortality were significantly higher in patients with increased FRA (P < 0.001 for both). In contrast, increased QRS duration in ECG predicted all-cause mortality (P < 0.05) but not arrhythmic events. In multivariate analysis, FRA was an independent predictor of both arrhythmic events and all-cause mortality. Using a combined criterion of increased FRA and LVEF < 30% yielded positive and negative predictive accuracies of 50% and 91% for arrhythmic events.

    CONCLUSION:

    In post-MI patients with left ventricular dysfunction, increased intra-QRS fragmentation in high-resolution magnetocardiography predicts arrhythmic events, whereas QRS duration in 12-lead ECG predicts all-cause mortality. Analysis of intra-QRS fragmentation by MCG may assist in guiding therapy of post-MI patients, for example, by selecting those who would benefit most from prophylactic implantable cardioverter-defibrillator therapy.

    PMID:
    16643362
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk